ENDV · Endonovo Therapeutics, Inc.
$0.00
At close · Sep 16
Going-concern doubt
— flagged Dec 29, 2023
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt as to its ability to continue as going concern within one year from issuance date of these unaudited consolidated financial statements.”View the 10-Q filed Dec 29, 2023
Market Cap
$31,875
Shares
318.75M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–0.00
Avg vol 30d730K
Short int519K · 0.2% float · 1.0d
Short vol100%
DataJan 2020–Sep 2026
Filing10-Q · Dec 29
Up next
filed Dec 29, 2023
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$255,723
Trailing 12 months
Net income (TTM)
−$4.40M
Trailing 12 months
Revenue growth YoY
-86.1%
Year over year
Operating margin
-1,023.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+779.4%
Year over year · more shares
Price change (1Y)
+0.0%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
0%
above
Price vs 50-day avg
0%
above
RSI (14)
45
neutral
MACD trend
Negative
52-week position
0%
near low
Momentum
relative strength
1-month return
0%
trailing
6-month return
0%
trailing
YTD return
0%
this year
Relative strength
−15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.16% of float · ▲ +0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−33%
Y/Y
Gross margin
410%
expanding
Free cash flow
$-681.4K
Balance sheet
$7.2M
net debt
Quant / Vol
risk profile
Volatility
541%
annualized · 1-yr
Max drawdown
−75%
past year
ATR
0.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
0%
Neutral
Price vs 50-day avg
0%
Neutral
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.16% of float · ▲ +0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $0
vs 200-day avg +0%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ENDV
this stock
Endonovo Therapeutics, Inc.
|
$31,875 | +0.0% | -32.9% | — | 0.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$130.06B | +13.9% | +46.2% | 29.9 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$79.83B | +2.3% | +20.8% | 19.2 | 2.5% |
|
ARGX
Argenx SE
|
$60.93B | +18.4% | — | — | 2.0% |
|
CSLLY
Csl Ltd
|
$59.64B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ENDV | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| SPY | -1.1% | -1.8% | +14.8% | -1.7% | +10.6% |
| vs SPY | +1.1% | +1.8% | -14.8% | +1.7% | -10.6% |